Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in Nat Med Retrieve available abstracts of 28 articles: HTML format

Single Articles

November 2025
1. KITYO C, Mambule IK, Musaazi J, Sokhela S, et al
   Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial.
   Nat Med. 2025 Nov 4. doi: 10.1038/s41591-025-04041.
   PubMed     Abstract available
   
   
   October 2025
2. COREY L, Ratevosian J, Beyrer C, Currier J, et al
   How HIV research drives health innovation in multiple diseases.
   Nat Med. 2025 Oct 24. doi: 10.1038/s41591-025-04019.
   PubMed    
   
   
   
3. RAMGOPAL MN, Lalezari JP, Pires Dos Santos AG, Krishnan P, et al
   Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study.
   Nat Med. 2025 Oct 15. doi: 10.1038/s41591-025-03993.
   PubMed     Abstract available
   
   
   August 2025
4. BOTEY-BATALLER J, van Unen N, Blaauw M, Vos WAJW, et al
   Genetic and molecular landscape of comorbidities in people living with HIV.
   Nat Med. 2025 Aug 20. doi: 10.1038/s41591-025-03887.
   PubMed     Abstract available
   
   
   June 2025
5. FERRAND RA, Dauya E, Chikwari CD, Bandason T, et al
   Integrated community-based HIV and sexual and reproductive health services for youth: a cluster-randomized trial.
   Nat Med. 2025 Jun 24. doi: 10.1038/s41591-025-03762.
   PubMed     Abstract available
   
   
   April 2025
6. 
   Extreme inequities in access to HIV treatment in Malawi.
   Nat Med. 2025 Apr 15. doi: 10.1038/s41591-025-03676.
   PubMed    
   
   
   
7. ZHANG Y, Li J, Xie Y, Wu D, et al
   Author Correction: Pay-it-forward incentives for hepatitis virus testing in men who have sex with men: a cluster randomized trial.
   Nat Med. 2025 Apr 9. doi: 10.1038/s41591-025-03690.
   PubMed    
   
   
   March 2025
8. PEKAR JE, Wang Y, Wang JC, Shao Y, et al
   Transmission dynamics of the 2022 mpox epidemic in New York City.
   Nat Med. 2025 Mar 25. doi: 10.1038/s41591-025-03526.
   PubMed     Abstract available
   
   
   
9. PONCE J, Okano JT, Low A, Dullie L, et al
   Extreme geographic misalignment of healthcare resources and HIV treatment deserts in Malawi.
   Nat Med. 2025 Mar 14. doi: 10.1038/s41591-025-03561.
   PubMed     Abstract available
   
   
   February 2025
10. COWAN FM, Shahmanesh M, Revill PA, Busza J, et al
    Preventing HIV in women in Africa.
    Nat Med. 2025 Feb 13. doi: 10.1038/s41591-025-03535.
    PubMed     Abstract available
    
    
    
11. BENGU N, Cromhout G, Adland E, Govender K, et al
    Author Correction: Sustained aviremia despite anti-retroviral therapy non-adherence in male children after in utero HIV transmission.
    Nat Med. 2025 Feb 5. doi: 10.1038/s41591-025-03555.
    PubMed    
    
    
    January 2025
12. JADLOWSKY JK, Hexner EO, Marshall A, Grupp SA, et al
    Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.
    Nat Med. 2025 Jan 20. doi: 10.1038/s41591-024-03478.
    PubMed     Abstract available
    
    
    
13. RAI MA, Blazkova J, Kardava L, Justement JS, et al
    Sustained virologic suppression of multidrug-resistant HIV in an individual treated with anti-CD4 domain 1 antibody and lenacapavir.
    Nat Med. 2025 Jan 3. doi: 10.1038/s41591-024-03357.
    PubMed     Abstract available
    
    
    December 2024
14. O'LEARY K
    Long-acting PrEP prevents HIV in women.
    Nat Med. 2024;30:3393.
    PubMed    
    
    
    November 2024
15. NYIRENDA J, Hardy OM, Silva Filho JD, Herder V, et al
    Spatially resolved single-cell atlas unveils a distinct cellular signature of fatal lung COVID-19 in a Malawian population.
    Nat Med. 2024 Nov 20. doi: 10.1038/s41591-024-03354.
    PubMed     Abstract available
    
    
    
16. 
    HIV-1 remission following stem cell transplant without CCR5Delta32 mutation.
    Nat Med. 2024 Nov 6. doi: 10.1038/s41591-024-03365.
    PubMed    
    
    
    
17. LAKHOO DP, Brink N, Radebe L, Craig MH, et al
    A systematic review and meta-analysis of heat exposure impacts on maternal, fetal and neonatal health.
    Nat Med. 2024 Nov 5. doi: 10.1038/s41591-024-03395.
    PubMed     Abstract available
    
    
    October 2024
18. CHU VT, Glascock A, Donnell D, Grabow C, et al
    Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome.
    Nat Med. 2024 Oct 3. doi: 10.1038/s41591-024-03274.
    PubMed     Abstract available
    
    
    September 2024
19. JULG B, Walker-Sperling VEK, Wagh K, Aid M, et al
    Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trial.
    Nat Med. 2024 Sep 12. doi: 10.1038/s41591-024-03247.
    PubMed     Abstract available
    
    
    
20. SAEZ-CIRION A, Mamez AC, Avettand-Fenoel V, Nabergoj M, et al
    Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells.
    Nat Med. 2024 Sep 2. doi: 10.1038/s41591-024-03277.
    PubMed     Abstract available
    
    
    August 2024
21. HEMONO R, Gatare E, Kayitesi L, Hunter LA, et al
    Effect of a digital school-based intervention on adolescent family planning and reproductive health in Rwanda: a cluster-randomized trial.
    Nat Med. 2024 Aug 23. doi: 10.1038/s41591-024-03205.
    PubMed     Abstract available
    
    
    
22. MULIYIL S
    HIV prevention through PrEP in cisgender women.
    Nat Med. 2024 Aug 6. doi: 10.1038/d41591-024-00058.
    PubMed    
    
    
    July 2024
23. SUN K, Bhiman JN, Tempia S, Kleynhans J, et al
    SARS-CoV-2 correlates of protection from infection against variants of concern.
    Nat Med. 2024 Jul 26. doi: 10.1038/s41591-024-03131.
    PubMed     Abstract available
    
    
    June 2024
24. MACHINGURA F
    Navigating the health frontiers of Africa's climate challenge.
    Nat Med. 2024 Jun 24. doi: 10.1038/s41591-024-03061.
    PubMed    
    
    
    
25. BENGU N, Cromhout G, Adland E, Govender K, et al
    Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
    Nat Med. 2024 Jun 6. doi: 10.1038/s41591-024-03105.
    PubMed     Abstract available
    
    
    
26. ADEPOJU P
    Meet the PrEP ambassadors who use social media to combat HIV.
    Nat Med. 2024;30:1510-1512.
    PubMed    
    
    
    March 2024
27. O'LEARY K
    Combination treatment for immune-mediated HIV remission.
    Nat Med. 2024 Mar 26. doi: 10.1038/d41591-024-00020.
    PubMed    
    
    
    
28. NARASIMHAN M, Hargreaves JR, Logie CH, Abdool-Karim Q, et al
    Self-care interventions for women's health and well-being.
    Nat Med. 2024 Mar 7. doi: 10.1038/s41591-024-02844.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.